煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模、佔有率和成長分析：按產品類型、劑型、應用和地區分類－2026-2033 年產業預測

2024 年全球菸鹼醯胺腺嘌呤二核苷酸 (NAD) 市場價值為 34.5 億美元，預計到 2033 年將從 2025 年的 39.7 億美元成長至 122.3 億美元，預測期（2026-2033 年）的複合年成長率為 15.1%。

全球對菸鹼醯胺腺嘌呤二核苷酸 (NAD) 產品的需求成長，主要受以下因素驅動：人們對健康老化的日益關注、細胞代謝研究的進展以及長壽和保健品的日益普及。隨著科學證據不斷增強，NAD 在細胞能量代謝中的關鍵作用日益凸顯，預計市場成長將加速，這主要得益於旨在應對與老齡化相關的健康挑戰的技術投資。臨床證據的累積和生產過程的改進也值得關注。然而，缺乏長期臨床數據、產品價格高昂、健康影響方面的監管不確定性以及其他健康解決方案的競爭等挑戰，可能會阻礙市場擴張。儘管存在這些障礙，但消費者、臨床醫生和研究人員對可靠配方的需求不斷成長，預示著 NAD 產品擁有強勁的發展前景。

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場按產品類型、劑型、應用和地區進行細分。依產品類型分類，可分為菸鹼醯胺核苷 (NR)、菸鹼醯胺單核苷酸 (NMN)、還原型 NAD (NADH) 和其他產物。依劑型分類，可分為膠囊/錠劑、粉劑及其他劑型。依應用分類，可分為膳食補充品、藥品、化妝品/個人護理用品、食品飲料、動物飼料和其他領域。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場的成長要素

醫藥領域對高純度菸鹼醯胺腺嘌呤二核苷酸 (NAD) 的需求日益成長，顯著推動了市場擴張。隨著 NAD 及其前體在治療和預防代謝紊亂以及應對與老齡化相關的健康問題方面備受關注，製造商被迫優先加強產能和品管措施。這種持續的需求促進了供應商和製造商之間緊密的合作關係，為多元化的生產策略和策略投資鋪平了道路。這些合作的最終目標是透過增強市場產能和韌性，以及促進 NAD 在臨床和研究領域的更廣泛應用，來滿足製藥業不斷變化的需求。

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場的限制因素

醫藥級煙醯胺腺嘌呤二核苷酸 (NA) 的高生產和純化成本對全球市場成長構成重大挑戰。供應商往往難以滿足嚴格的品質和監管標準，這會阻礙業務擴張，尤其對中小企業而言更是如此。不斷上漲的生產成本也會擠壓現有企業的利潤空間，限制其在生產和研發方面的投資能力。此外，對專用設備和先進品管流程的大量資本投入也構成了很高的市場准入壁壘，阻礙了市場參與企業。

全球煙醯胺腺嘌呤二核苷酸（NAD）市場趨勢

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場呈現出顯著的發展趨勢，其治療應用範圍不斷擴大，尤其是在神經退化性疾病、代謝紊亂和老齡化等領域的研究。這種轉變正在加強製藥公司與專注於研發的生物技術公司之間的合作。對基於機制的治療方法和個人化給藥方案的日益重視，正在推動製劑和給藥方法的創新，而這些對於成功的臨床應用至關重要。隨著與學術界合作的拓展，市場適應症正在多元化，從而重塑供應鏈，使其朝向專業製劑方向發展。這一趨勢正在推動生命科學領域的成分開發和策略聯盟，反映出市場對 NAD 相關產品的強勁需求。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模：按產品類型分類

• 煙鹼醯胺核苷（NR）
• 菸鹼醯胺單核苷酸（NMN）
• 還原型 NAD (NADH)
• 其他

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模：按形式分類

• 膠囊和片劑
• 粉末
• 其他

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模：按應用領域分類

• 營養補充品
• 製藥
• 化妝品和個人護理
• 食品/飲料
• 動物飼料
• 其他

全球煙醯胺腺嘌呤二核苷酸 (NAD) 市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Merck KGaA
• Thermo Fisher Scientific
• Bontac Bio-engineering
• ChromaDex
• Elysium Health
• Bota Biosciences
• Shenzhen GeneHaven
• Brother Enterprises
• Anhui Prochem
• Sinnova Bioway
• Lasons India
• Zhejiang Cheng Yi
• Redox Bio
• PepTech
• Yantai Longlife
• Novozymes
• TCI Chemicals
• Sisco Research Laboratories
• MedChemExpress
• Bio-Techne

結論與建議

Global Nicotinamide Adenine Dinucleotide Market size was valued at USD 3.45 Billion in 2024 and is poised to grow from USD 3.97 Billion in 2025 to USD 12.23 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The global demand for nicotinamide adenine dinucleotide (NAD) products is significantly influenced by the growing focus on healthy aging, advancements in cellular metabolism research, and the rising popularity of longevity and wellness supplements. As scientific validation for NAD's crucial role in cellular energy metabolism strengthens, market growth is anticipated to accelerate, fueled by investments in technologies aimed at age-related health solutions. The collaboration between clinical support and improved manufacturing processes is also noteworthy. However, challenges such as limited long-term clinical data, high product pricing, regulatory uncertainties regarding health claims, and competition from alternative wellness solutions could hinder market expansion. Despite these hurdles, the increasing consumer, clinician, and researcher demand for dependable formulations suggests a robust future for NAD products.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nicotinamide Adenine Dinucleotide market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nicotinamide Adenine Dinucleotide Market Segments Analysis

Global nicotinamide adenine dinucleotide market is segmented by product type, form, application, and region. Based on product type, the market is segmented into Nicotinamide Riboside (NR), Nicotinamide Mononucleotide (NMN), Reduced NAD (NADH), and others. Based on form, the market is segmented into capsules and tablets, powder, and others. Based on application, the market is segmented into dietary supplements, pharmaceuticals, cosmetics and personal care, food and beverages, animal nutrition, and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Nicotinamide Adenine Dinucleotide Market

The increasing need for high-purity Nicotinamide Adenine Dinucleotide (NAD) in pharmaceutical applications is significantly propelling market expansion. As NAD and its precursors gain traction for treating and preventing metabolic disorders and addressing age-related health concerns, manufacturers are compelled to enhance production capabilities and prioritize quality control measures. This sustained demand fosters strong relationships between suppliers and manufacturers, paving the way for diverse manufacturing strategies and strategic investments. Such collaborations ultimately aim to bolster market capacity and resilience, facilitating the broader utilization of NAD in clinical and research settings, thereby meeting the evolving needs of the pharmaceutical industry.

Restraints in the Global Nicotinamide Adenine Dinucleotide Market

The growth of the Global Nicotinamide Adenine Dinucleotide market faces significant challenges due to the substantial manufacturing and purification costs associated with pharmaceutical-grade NA. Suppliers often struggle to meet rigorous quality and regulatory standards, which can constrain expansion efforts, particularly for smaller companies. Elevated production costs can also erode profit margins for established firms, potentially limiting their capacity to invest in production and research and development. Additionally, the necessity for significant capital investment in specialized equipment and advanced quality control processes creates a high barrier to entry, thereby hindering market entry and slowing the supply of products from various market participants.

Market Trends of the Global Nicotinamide Adenine Dinucleotide Market

The Global Nicotinamide Adenine Dinucleotide (NAD) market is witnessing a significant trend characterized by the expansion of therapeutic applications, particularly in neurodegenerative, metabolic, and age-related research. This shift is fostering increased collaborations between pharmaceutical companies and biotech firms focused on research and development. A notable emphasis on mechanism-of-action-driven treatments and individualized dosing regimens has spurred innovation in formulations and delivery methods, vital for successful clinical applications. As collaborations extend to academia, the market is experiencing a diversification of indications, thereby reshaping supply chain dynamics towards specialized formulations. This trend is advancing ingredient development and strategic partnerships within the life sciences sector, reflecting a robust demand for NAD-related products.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Nicotinamide Adenine Dinucleotide Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Nicotinamide Riboside (NR)
• Nicotinamide Mononucleotide (NMN)
• Reduced NAD (NADH)
• Others

Global Nicotinamide Adenine Dinucleotide Market Size by Form & CAGR (2026-2033)

• Market Overview
• Capsules and Tablets
• Powder
• Others

Global Nicotinamide Adenine Dinucleotide Market Size by Application & CAGR (2026-2033)

• Market Overview
• Dietary Supplements
• Pharmaceuticals
• Cosmetics and Personal Care
• Food and Beverages
• Animal Nutrition
• Others

Global Nicotinamide Adenine Dinucleotide Market Size & CAGR (2026-2033)

• North America (Product Type, Form, Application)
  • US
  • Canada
• Europe (Product Type, Form, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Form, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Form, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Form, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bontac Bio-engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChromaDex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elysium Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bota Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen GeneHaven
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brother Enterprises
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Prochem
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinnova Bioway
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lasons India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Cheng Yi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Redox Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PepTech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yantai Longlife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TCI Chemicals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sisco Research Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedChemExpress
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations